This inventor holds 2 USPTO granted patents. Top assignees: Beth Israel Deaconess Medical Center, Inc., Boston University. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2010-2012
Title: Innovations of Cheng T Lin
Introduction
Cheng T Lin is a notable inventor based in Fresh Meadow, NY. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on genipin derivatives. With a total of two patents to his name, Lin's inventions focus on addressing critical health issues.
Latest Patents
Cheng T Lin's latest patents include formulations of genipin derivatives and their pharmaceutical compositions. These compositions are designed to inhibit the activity of uncoupling protein-2 (UCP2). They are particularly useful in treating conditions such as deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in mammals. His work in this area has the potential to impact the treatment of various metabolic disorders.
Career Highlights
Throughout his career, Cheng T Lin has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and Boston University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Cheng T Lin has collaborated with notable colleagues, including Chen-Yu Zhang and Bradford B Lowell. These partnerships have further enhanced his research and development efforts in the pharmaceutical domain.
Conclusion
Cheng T Lin's innovative work on genipin derivatives showcases his commitment to advancing medical science. His contributions have the potential to improve treatment options for various health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile